Structure-guided design of peptide-based tryptase inhibitors

被引：24

作者：

McGrath, ME ^{[1
]}

Sprengeler, PA ^{[1
]}

Hirschbein, B ^{[1
]}

Somoza, JR ^{[1
]}

Lehoux, I ^{[1
]}

Janc, JW ^{[1
]}

Gjerstad, E ^{[1
]}

Graupe, M ^{[1
]}

Estiarte, A ^{[1
]}

Venkataramani, C ^{[1
]}

Liu, Y ^{[1
]}

Yee, R ^{[1
]}

Ho, JD ^{[1
]}

Green, MJ ^{[1
]}

Lee, CS ^{[1
]}

Liu, L ^{[1
]}

Tai, V ^{[1
]}

Spencer, J ^{[1
]}

Sperandio, D ^{[1
]}

Katz, BA ^{[1
]}

机构：

[1] Celera Genom Inc, San Francisco, CA 94080 USA

来源：

BIOCHEMISTRY | 2006年 / 45卷 / 19期

关键词：

D O I：

10.1021/bi060173m

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Improved peptide- based inhibitors of human, tryptase were discovered using information gleaned from tripeptide library screening and structure- guided design methods, including fragment screening. Our efforts sought to improve this class of inhibitors by replacing the traditional Lys or Arg P1 element. The optimized compounds display low nanomolar potency against the mast cell target and several hundredfold selectivity with respect to serine protease off targets. Thus, replacement of Lys/ Arg at P1 in a peptide-like scaffold does not need to be accompanied by a loss in target affinity.

引用

收藏

页码：5964 / 5973

页数：10

相关论文

共 42 条

[1] Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2 [J].

Akers, IA ;

Parsons, M ;

Hill, MR ;

Hollenberg, MD ;

Sanjar, S ;

Laurent, GJ ;

McAnulty, RJ .

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2000, 278 (01) :L193-L201

[2] Tryptase and agonists of PAR-2 induce the proliferation of human airway smooth muscle cells [J].

Berger, P ;

Perng, DW ;

Thabrew, H ;

Compton, SJ ;

Cairns, JA ;

McEuen, AR ;

Marthan, R ;

De Lara, JMT ;

Walls, AF .

JOURNAL OF APPLIED PHYSIOLOGY, 2001, 91 (03) :1372-1379

[3] Synthesis of potent and highly selective nonguanidine azetidinone inhibitors of human tryptase [J].

Bisacchi, GS ;

Slusarchyk, WA ;

Bolton, SA ;

Hartl, KS ;

Jacobs, G ;

Mathur, A ;

Meng, W ;

Ogletree, ML ;

Pi, ZL ;

Sutton, JC ;

Treuner, U ;

Zahler, R ;

Zhao, GH ;

Seller, SM .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (09) :2227-2231

[4] High-throughput crystallography for lead discovery in drug design [J].

Blundell, TL ;

Jhoti, H ;

Abell, C .

NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (01) :45-54

[5] FREE R-VALUE - A NOVEL STATISTICAL QUANTITY FOR ASSESSING THE ACCURACY OF CRYSTAL-STRUCTURES [J].

BRUNGER, AT .

NATURE, 1992, 355 (6359) :472-475

[6]

Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254

[7]

BRUNGER AT, 1990, X PLOR MANUAL VERSIO, P187

[8] Potent selective nonpeptidic inhibitors of human lung tryptase [J].

Burgess, LE ;

Newhouse, BJ ;

Ibrahim, P ;

Rizzi, J ;

Kashem, MA ;

Hartman, A ;

Brandhuber, BJ ;

Wright, CD ;

Thomson, DS ;

Vigers, GPA ;

Koch, K .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (15) :8348-8352

[9] A family of phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug design [J].

Card, GL ;

Blasdel, L ;

England, BP ;

Zhang, C ;

Suzuki, Y ;

Gillette, S ;

Fong, D ;

Ibrahim, PN ;

Artis, DR ;

Bollag, G ;

Milburn, MV ;

Kim, SH ;

Schlessinger, J ;

Zhang, KYJ .

NATURE BIOTECHNOLOGY, 2005, 23 (02) :201-207

[10]

Chan AWE, 1996, BIOORGAN MED CHEM, V4, P1673

← 1 2 3 4 5 →